In addition, from the perspective of immune exclusion, ALK5 acts on stromal cells in the intra- or extratumoral area to promote the formation of the stromal barrier, preventing T cells from infiltrating into the tumor and ultimately promoting refractory cancer and resistance to immunotherapy. The gene discussed is TGFBR1; the disease is cancer.